# A Study to Test How BI 690517 is Taken up in the Body of People With and Without Liver Problems

> **NCT05731908** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 28 (actual)

## Conditions studied

- Liver Diseases
- Healthy

## Interventions

- **DRUG:** BI 690517

## Key facts

- **NCT ID:** NCT05731908
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-02-21
- **Primary completion:** 2023-04-13
- **Final completion:** 2023-04-13
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2024-09-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05731908

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05731908, "A Study to Test How BI 690517 is Taken up in the Body of People With and Without Liver Problems". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05731908. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*